Affymax, Inc. (NASDAQOTH:AFFY)

CAPS Rating: 1 out of 5

The Company is a biopharmaceutical company developing novel peptide-based drug candidates to improve the treatment of serious and often life-threatening conditions.

Featured Broker Partners


Advertisement